156 related articles for article (PubMed ID: 38008135)
1. IUPHAR review- Preclinical models of neuropathic pain: Evaluating multifunctional properties of natural cannabinoid receptors ligands.
Benamar K
Pharmacol Res; 2024 Jan; 199():107013. PubMed ID: 38008135
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction.
Blanton H; Yin L; Duong J; Benamar K
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555111
[TBL] [Abstract][Full Text] [Related]
3. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J; Weyer-Menkhoff I; Tegeder I
Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
[TBL] [Abstract][Full Text] [Related]
4. Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model.
Eeswara A; Pacheco-Spiewak A; Jergova S; Sagen J
PLoS One; 2023; 18(3):e0282920. PubMed ID: 36913400
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement.
Bilbrey JA; Ortiz YT; Felix JS; McMahon LR; Wilkerson JL
Psychopharmacology (Berl); 2022 May; 239(5):1475-1486. PubMed ID: 34846548
[TBL] [Abstract][Full Text] [Related]
6. β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties.
Fidyt K; Fiedorowicz A; Strządała L; Szumny A
Cancer Med; 2016 Oct; 5(10):3007-3017. PubMed ID: 27696789
[TBL] [Abstract][Full Text] [Related]
7. Cannabis constituent synergy in a mouse neuropathic pain model.
Casey SL; Atwal N; Vaughan CW
Pain; 2017 Dec; 158(12):2452-2460. PubMed ID: 28885457
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT
Malvestio RB; Medeiros P; Negrini-Ferrari SE; Oliveira-Silva M; Medeiros AC; Padovan CM; Luongo L; Maione S; Coimbra NC; de Freitas RL
Brain Res Bull; 2021 Sep; 174():323-338. PubMed ID: 34192579
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Antiallodynic Activity of Cannabidiol Analogue on Peripheral Neuropathy in Mice.
Marques GVL; Braga AV; Silva IR; de Souza ARB; Kohlhoff M; César IC; Machado RR; Oliveira RB
Chem Biodivers; 2024 Apr; 21(4):e202301935. PubMed ID: 38363210
[TBL] [Abstract][Full Text] [Related]
10. Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT
Aguiar DD; da Costa Oliveira C; Fonseca FCS; de Almeida DL; Campos Pereira WV; Guimarães FS; Perez AC; Duarte IDG; Romero TRL
Biochem Biophys Res Commun; 2023 Jun; 660():58-64. PubMed ID: 37068389
[TBL] [Abstract][Full Text] [Related]
11. The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.
Klauke AL; Racz I; Pradier B; Markert A; Zimmer AM; Gertsch J; Zimmer A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):608-20. PubMed ID: 24210682
[TBL] [Abstract][Full Text] [Related]
12. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
[TBL] [Abstract][Full Text] [Related]
13. Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia.
Yokubaitis CG; Jessani HN; Li H; Amodea AK; Ward SJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799861
[TBL] [Abstract][Full Text] [Related]
14. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation.
Dos Santos R; Veras F; Netto G; Elisei L; Sorgi C; Faccioli L; Galdino G
J Pharm Pharmacol; 2023 Apr; 75(5):655-665. PubMed ID: 36946366
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
Mlost J; Bryk M; Starowicz K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain.
Hoggart B; Ratcliffe S; Ehler E; Simpson KH; Hovorka J; Lejčko J; Taylor L; Lauder H; Serpell M
J Neurol; 2015 Jan; 262(1):27-40. PubMed ID: 25270679
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors.
Silva-Cardoso GK; Lazarini-Lopes W; Hallak JE; Crippa JA; Zuardi AW; Garcia-Cairasco N; Leite-Panissi CRA
Neuropharmacology; 2021 Oct; 197():108712. PubMed ID: 34274349
[TBL] [Abstract][Full Text] [Related]
20. Single and combined effects of Δ
King KM; Myers AM; Soroka-Monzo AJ; Tuma RF; Tallarida RJ; Walker EA; Ward SJ
Br J Pharmacol; 2017 Sep; 174(17):2832-2841. PubMed ID: 28548225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
